Information  X 
Enter a valid email address

Allied Minds PLC Ord 1P (ALM)

Related News

08-Feb-2017 12:10 PM

Broker Forecast - Credit Suisse issues a broker note on Allied Minds PLC

Credit Suisse today initiates coverage of Allied Minds PLC (LON:ALM) with a neutral investment rating and price target of 400p. Story provided by StockMarketWire.com...
25-Aug-2016 07:43 AM

Allied Minds losses rise

Allied Minds posts a pre-tax loss of $52.2m for the six months to the end of June - up froma a restated $39.8m last time. Revenues totalled $1.3 - down from $1.5m a year ago. Operating losses rose to $51.3m from $39.6m. Chief executive Chris Silva said
22-Aug-2016 07:47 AM

Allied Minds secures $20m debt facility

Allied Minds has secured a $20 million, one-year revolving debt facility from Silicon Valley Bank. The facility is secured over certain assets of the group. To secure the facility, the group was required to meet certain financial strength tests set by
25-May-2016 08:14 AM

ABLS II completes drug feasibility programme

Allied-Bristol Life Sciences - Allied Minds' partnership with Bristol-Myers Squibb Company - has successfully completed the drug candidate feasibility programme at ABLS II and has approved up to $15 million to fund further development of the lead opt
16-Mar-2016 09:26 AM

ABLS agrees licence with NYU

Allied-Bristol Life Sciences - a biopharmaceutical enterprise jointly owned by Allied Minds and Bristol-Myers Squibb Co - has launched a new subsidiary, iβeCa Therapeutics, to license proprietary compounds from NYU School of Medicine that target the
09-Feb-2016 07:51 AM

Allied Minds sees positive progress

Allied Minds saw positive progress in 2015 with its subsidiaries meeting or exceeding commercial milestones in nearly all instances. Chief executive Chris Silva said: "We have embarked on exciting collaborations with industry leaders such as Bristol
15-Jan-2016 07:52 AM

Allied Minds appoints independent non-exec

Allied Minds has appointed Jill Smith, former chairman, CEO and president of DigitalGlobe Inc, as an independent non-executive director. Allied Minds says Smith brings a wealth of expertise to help oversee the company's growing portfolio of life-sc
17-Sep-2015 08:43 AM

Allied Minds announces formation of HawkEye 360

Allied Minds has announced the formation of HawkEye 360, which will use a constellation of small satellites in low Earth orbit capable of detecting wireless signals that can be used to track and monitor global transportation networks, assist with emergenc
27-Aug-2015 09:15 AM

Allied Minds losses widen

Allied Minds posts a loss of $39.1m for the six months to the end of June compared with $27.2m a year ago. Revenue fell to $1.5m (HY14: $2.9m) which was primarily attributable to the lower product revenue at RF Biocidics, offset by the grant revenue at S
29-May-2015 09:30 AM

Allied Minds resolutions passed at AGM

Allied Minds has confirmed that all of the resolutions proposed at the annual general meeting yesterday were passed by the shareholders on a poll. At 9:30am: (LON:ALM) Allied Minds PLC Ord 1p share price was -0.75p at 611.25p Story provided by Stock
28-Apr-2015 12:13 PM

Allied Minds holds capital markets day

Allied Minds has announced that it is holding a Capital Markets Day for analysts and investors today in London, which will include presentations from a number of Allied Minds' subsidiaries. The company has confirmed that no new current trading infor
28-Apr-2015 09:00 AM

Allied Minds operating losses rise

Allied Minds posts an operating loss of $57.9m for the year to the end of December - up from $42.6m last time. Revenues rose to $7.7m from $2.9m but selling, general and administrative costs increased to $38.0m from $27.5m while R&D expenses rose to $22
26-Mar-2015 02:34 PM

Allied Minds schedules FY results

Allied Minds, an innovative US science and technology development and commercialisation company, will announce its full year 2014 results at 7 a.m. on 28 April. Allied Minds will also host a capital markets day event on the same day, to be held at Etc. V
10-Mar-2015 09:04 AM

Allied Minds announces formation of BridgeSat

Allied Minds, an innovative US science and technology development and commercialisation company, has announced the formation of BridgeSat Inc, which is building an optical connectivity system to improve the wireless transfer of data from satellites. Bri
08-Jan-2015 08:56 AM

Allied Minds unit gets US patent

Allied Minds subsidiary SciFluor Life Sciences has been awarded a US patent covering the novel compound SF0034, a potent and selective neuronal potassium channel activator, designed to be a significantly improved version of the first-in-class KCNQ2/3 act
04-Dec-2014 09:03 AM

Allied Minds unit gets US patent

Allied Minds subsidiary SciFluor Life Sciences has been a warded a US patent. SciFluor Life Sciences, an emerging clinical stage biopharmaceutical company that creates innovative therapeutics for patients with ophthalmologic and neurologic disease, said
05-Nov-2014 08:06 AM

Allied Minds appoints Donna See as vice-president

Allied Minds, an innovative US science and technology development and commercialisation company, has appointed Donna See as vice-president to lead the firm's partnerships with US research universities. She brings more than 14 years of experience in
30-Oct-2014 08:04 AM

Allied Minds forms Seamless Devices Inc

Allied Minds is entering into an exclusive, worldwide licensing agreement with Columbia University that has led to the formation of a new subsidiary, Seamless Devices, Inc. Seamless Devices is developing applications for a novel technique in analog sig
07-Oct-2014 07:51 AM

Allied Minds launches Novare Pharmaceuticals

Allied Minds, an innovative US science and technology development and commercialisation company, has announced the launch of Novare Pharmaceuticals. Novare is a biotechnology company focused on developing therapeutic products that help the body replenis
03-Oct-2014 07:57 AM

ABLS appoints Satish Jindal

Allied-Bristol Life Sciences, a jointly owned enterprise between Allied Minds and Bristol-Myers Squibb Co, has announced that Satish Jindal, Ph.D., formerly vice-president of R&D within Bristol-Myers, has been appointed to lead the company's efforts
27-Aug-2014 09:18 AM

Allied Minds sets up Whitewood Encryption

Allied Minds has announced the formation of Whitewood Encryption Systems, a builder of next-generation systems of data encryption that leverage advanced cryptography technologies emerging from US centres of research excellence. Whitewood was founded upo
04-Aug-2014 08:23 AM

Allied Minds and BMS form new enterprise

Allied Minds and Bristol-Myers Squibb Company have formed Allied-Bristol Life Sciences LLC, a new jointly owned enterprise created to identify and foster research and pre-clinical development of biopharmaceutical innovations from leading university resea
01-Jun-2010 08:57 AM

Alphameric completes sale of ASL to Orbis

Alphameric has completed the disposal of Alphameric Solutions (ASL) to Orbis Holdings. The disposal was previously announced on 7 May and approved by shareholders on 25 May. James Soulsby has resigned from the board and ceases to be a director of the c
28-May-2010 05:56 PM

Director Deals - Alphameric Plc (ALM)

Mike McLaren, Financial Director, bought 35,713 shares in the company on the 28th May 2010 at a price of 28.00p. The Director now holds 267,625 shares. NOTE: Story provided by Business Financial Newswire...
28-May-2010 05:41 PM

Director Deals - Alphameric Plc (ALM)

Peter Bertram, Chairman, bought 35,713 shares in the company on the 28th May 2010 at a price of 28.00p. The Director now holds 35,713 shares representing 0.00% of the shares in issue. NOTE: Story provided by Business Financial Newswire...
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t